Huma MG Care:

The leading digital platform for Myasthenia Gravis management

Over 500 Myasthenia Gravis patients are using Huma MG Care

Improved early detection of symptom exacerbations

Improved early detection of symptom exacerbations

Enhanced patient-clinician communication

Enhanced patient-clinician communication

Personalized care through Coaching

Personalized care through Coaching

Better symptom control and treatment optimization

Better symptom control and treatment optimization

Myasthenia Gravis affects daily life and puts patients at risk of exacerbations. HumaMG can help.

Myasthenia Gravis (MG) is a rare autoimmune disease causing muscle weakness that impacts talking, swallowing, breathing, and mobility. Symptoms vary, worsen over time, and can lead to myasthenic crises requiring hospitalization (up to 20% of patients). HumaMG empowers patients with tools for symptom tracking, education, and proactive care to improve quality of life and reduce healthcare burdens.

HumaMG is used across healthcare providers in Europe, United Kingdom and United States 

HumaMG is used across healthcare providers in Europe, United Kingdom and United States 

HumaMG leverages Huma's EU MDR Class IIb and FDA Class II regulated Software as a Medical Device (SaMD), evaluated for safety and efficiency.

How it works

Patient App

Patient App

Patients use the HumaMG app (iOS, Android) to access MG-specific educational materials, track symptoms using the MG-ADL questionnaire, and monitor changes over time.

Patients use the HumaMG app (iOS, Android) to access MG-specific educational materials, track symptoms using the MG-ADL questionnaire, and monitor changes over time.

Clinician Portal

Clinician Portal

Care teams use the web-based dashboard to view patient-reported data in real time, detect early signs of exacerbations, identify triggers, and make proactive decisions for personalized care.

Care teams use the web-based dashboard to view patient-reported data in real time, detect early signs of exacerbations, identify triggers, and make proactive decisions for personalized care.

Our data

10,000+

Data points from MG patients

500+

Patients since September 2024

75%

Patient engagement in HCP led deployments

Huma MG AI models:

A leap in quantifying MG symptoms

A leap in quantifying MG symptoms

First and only FDA-cleared AI-enabled at-home QMG (to be approved in 2026)

Voice assessments, Ptosis,
Arm fatigue

No device needed beyond a smartphone Model trained on data labelled by leading medical researchers

Take the next step

Tell us what you’re solving for and a Huma expert will help you find the best solution.

Take the next step

Tell us what you’re solving for and a Huma expert will help you find the best solution.

Take the next step

Tell us what you’re solving for and a Huma expert will help you find the best solution.